Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Aerovate Therapeutics, Inc. (AVTE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 Dake Benjamin T (SEE REMARKS) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 9,742 shares @ $15.4785, valued at $150.8k
Sold 541 shares @ $16.2451, valued at $8.8k
Exercised 905 options to buy @ $1.74, valued at $1.6k
Exercised 1,507 options to buy @ $1.74, valued at $2.6k
Exercised 1,018 options to buy @ $2.14, valued at $2.2k
Exercised 6,853 options to buy @ $2.14, valued at $14.7k
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 NOYES TIMOTHY P (CEO) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 4,522 shares @ $18.1106, valued at $81.9k
Exercised 4,522 options to buy @ $2.14, valued at $9.7k
07/11/2023 4 Dable Habib J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $18.08, valued at $452k
07/07/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2023 4 NIVEN RALPH (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 2,031 shares @ $17.2337, valued at $35k
Sold 219 shares @ $17.8686, valued at $3.9k
Exercised 450 options to buy @ $1.74, valued at $783
Exercised 200 options to buy @ $1.74, valued at $348
Exercised 200 options to buy @ $2.14, valued at $428
Exercised 650 options to buy @ $2.14, valued at $1.4k
Exercised 750 options to buy @ $2.14, valued at $1.6k
07/05/2023 4 NOYES TIMOTHY P (CEO) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 10,000 shares @ $18, valued at $180k
Exercised 10,000 options to buy @ $2.14, valued at $21.4k
06/08/2023 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/08/2023 4 Dake Benjamin T (SEE REMARKS) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 10,268 shares @ $16.2798, valued at $167.2k
Sold 15 shares @ $16.975, valued at $254.6
Exercised 905 options to buy @ $1.74, valued at $1.6k
Exercised 1,507 options to buy @ $1.74, valued at $2.6k
Exercised 1,018 options to buy @ $2.14, valued at $2.2k
Exercised 6,853 options to buy @ $2.14, valued at $14.7k
06/08/2023 4 Santel Donald J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/08/2023 4 Katabi Maha (10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/08/2023 4 GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/08/2023 4 Resnick Joshua (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/08/2023 4 Iwicki Mark T (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/08/2023 4 Dorval Allison (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $16.3, valued at $203.8k
06/07/2023 4 NIVEN RALPH (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 2,250 shares @ $16.256, valued at $36.6k
Exercised 450 options to buy @ $1.74, valued at $783
Exercised 200 options to buy @ $1.74, valued at $348
Exercised 200 options to buy @ $2.14, valued at $428
Exercised 650 options to buy @ $2.14, valued at $1.4k
Exercised 750 options to buy @ $2.14, valued at $1.6k
05/23/2023 4 Gillies Hunter (CHIEF MEDICAL OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 65 shares @ $19.5, valued at $1.3k
Exercised 65 options to buy @ $1.74, valued at $113.1
05/19/2023 4 Gillies Hunter (CHIEF MEDICAL OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 1,090 shares @ $19.5925, valued at $21.4k
Exercised 1,090 options to buy @ $1.74, valued at $1.9k
05/09/2023 4 NIVEN RALPH (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 2,045 shares @ $20.793, valued at $42.5k
Sold 205 shares @ $21.6348, valued at $4.4k
Exercised 450 options to buy @ $1.74, valued at $783
Exercised 200 options to buy @ $1.74, valued at $348
Exercised 200 options to buy @ $2.14, valued at $428
Exercised 650 options to buy @ $2.14, valued at $1.4k
Exercised 750 options to buy @ $2.14, valued at $1.6k
05/09/2023 4 Dake Benjamin T (SEE REMARKS) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 8,685 shares @ $21.6241, valued at $187.8k
Sold 1,599 shares @ $22.7358, valued at $36.4k
Exercised 906 options to buy @ $1.74, valued at $1.6k
Exercised 1,507 options to buy @ $1.74, valued at $2.6k
Exercised 1,018 options to buy @ $2.14, valued at $2.2k
Exercised 6,853 options to buy @ $2.14, valued at $14.7k
05/05/2023 4 Verwijs Marinus (SENIOR VICE PRESIDENT, CMC) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 759 shares @ $20.7897, valued at $15.8k
05/03/2023 4 NOYES TIMOTHY P (CEO) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 15,000 shares @ $20.6059, valued at $309.1k
Sold 693 shares @ $21.15, valued at $14.7k
Exercised 15,000 options to buy @ $2.14, valued at $32.1k
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 NOYES TIMOTHY P (CEO) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 9,172 shares @ $19.155, valued at $175.7k
Sold 5,828 shares @ $19.7712, valued at $115.2k
Exercised 15,000 options to buy @ $2.14, valued at $32.1k
03/08/2023 4 NOYES TIMOTHY P (CEO) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 139,067 options to buy @ $23.03, valued at $3.2M
03/08/2023 4 Dake Benjamin T (SEE REMARKS) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 10,067 shares @ $23.7098, valued at $238.7k
Sold 215 shares @ $24.4977, valued at $5.3k
Exercised 906 options to buy @ $1.74, valued at $1.6k
Exercised 1,506 options to buy @ $1.74, valued at $2.6k
Exercised 1,018 options to buy @ $2.14, valued at $2.2k
Exercised 6,852 options to buy @ $2.14, valued at $14.7k
03/08/2023 4 NIVEN RALPH (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 2,205 shares @ $23.727, valued at $52.3k
Sold 45 shares @ $24.924, valued at $1.1k
Exercised 450 options to buy @ $1.74, valued at $783
Exercised 200 options to buy @ $1.74, valued at $348
Exercised 200 options to buy @ $2.14, valued at $428
Exercised 650 options to buy @ $2.14, valued at $1.4k
Exercised 750 options to buy @ $2.14, valued at $1.6k
02/08/2023 4 Verwijs Marinus (SENIOR VICE PRESIDENT, CMC) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 62,000 options to buy @ $25.57, valued at $1.6M
02/08/2023 4 Eldridge George A (SEE REMARKS) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 85,000 options to buy @ $25.57, valued at $2.2M
02/08/2023 4 Gillies Hunter (CHIEF MEDICAL OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 62,000 options to buy @ $25.57, valued at $1.6M
02/08/2023 4 Dake Benjamin T (SEE REMARKS) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 8,858 shares @ $24.5205, valued at $217.2k
Sold 1,426 shares @ $25.0201, valued at $35.7k
Exercised 905 options to buy @ $1.74, valued at $1.6k
Exercised 1,507 options to buy @ $1.74, valued at $2.6k
Exercised 1,019 options to buy @ $2.14, valued at $2.2k
Exercised 6,853 options to buy @ $2.14, valued at $14.7k
Granted 62,000 options to buy @ $25.57, valued at $1.6M
02/08/2023 4 NIVEN RALPH (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Sold 2,250 shares @ $24.272, valued at $54.6k
Exercised 450 options to buy @ $1.74, valued at $783
Exercised 200 options to buy @ $1.74, valued at $348
Exercised 200 options to buy @ $2.14, valued at $428
Exercised 650 options to buy @ $2.14, valued at $1.4k
Exercised 750 options to buy @ $2.14, valued at $1.6k
Granted 62,000 options to buy @ $25.57, valued at $1.6M
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2023 4 Santel Donald J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $23.44, valued at $586k
Granted 2,519 options to buy @ $23.44, valued at $59k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy